Lineagen, a US-based life sciences firm, has secured $12.17m in the second and final tranche of its overall $15.8m series C.
University Venture Fund, the venturing arm of Utah University, was one of the backers in the round, which was led by HealthQuest Capital. New investors Petra Capital Partners and Mountain Group Partners were joined by existing backers Sanderling Ventures, Signal Peak Ventures, PrairieGold Venture Partners, Mesa Verde Venture Partners, Archipel Capital, and KickStart Ventures. Partners from Petra Capital and…
